In a letter to Congress, 249 organizations made the case for how pharmacy direct and indirect remuneration, or DIR fees, affect seniors and pharmacies.
John King, CEO of pharmacy technology provider OmniSYS, discusses the challenges that COVID-19 brought to the industry and how his company has helped pharmacies find solutions.